| The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE | 
 | ||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE | 
| ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | 10,882,542 | 5,360,858 | SH | SOLE | 5,360,858 | 0 | 0 | |||
| ADAGIO MED HLDGS INC | COM | 00534B100 | 7,898,997 | 9,812,419 | SH | SOLE | 9,812,419 | 0 | 0 | |||
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 6,917,122 | 930,972 | SH | SOLE | 930,972 | 0 | 0 | |||
| ADMA BIOLOGICS INC | COM | 000899104 | 27,244,943 | 1,373,233 | SH | SOLE | 1,373,233 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 32,099,021 | 792,960 | SH | SOLE | 792,960 | 0 | 0 | |||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 53,336,143 | 9,275,851 | SH | SOLE | 9,275,851 | 0 | 0 | |||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 175,150,540 | 21,464,527 | SH | SOLE | 21,464,527 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 27,875,192 | 7,874,348 | SH | SOLE | 7,874,348 | 0 | 0 | |||
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 7,789,600 | 2,140,000 | SH | SOLE | 2,140,000 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 41,946,575 | 1,122,767 | SH | SOLE | 1,122,767 | 0 | 0 | |||
| APPLIED THERAPEUTICS INC | COM | 03828A101 | 420,454 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | |||
| APYX MEDICAL CORPORATION | COM | 03837C106 | 205,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 10,808,903 | 3,727,208 | SH | SOLE | 3,727,208 | 0 | 0 | |||
| ARCELLX INC | COMMON STOCK | 03940C100 | 191,976,957 | 2,926,478 | SH | SOLE | 2,926,478 | 0 | 0 | |||
| ARGENX SE | SPONSORED ADR | 04016X101 | 35,221,886 | 59,510 | SH | SOLE | 59,510 | 0 | 0 | |||
| ARTIVION INC | COM | 228903100 | 68,669,220 | 2,793,703 | SH | SOLE | 2,793,703 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 34,632,142 | 6,485,420 | SH | SOLE | 6,485,420 | 0 | 0 | |||
| ATHIRA PHARMA INC | COM | 04746L104 | 1,539,304 | 5,402,964 | SH | SOLE | 5,402,964 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 4,165,200 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | |||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 41,416,129 | 355,107 | SH | SOLE | 355,107 | 0 | 0 | |||
| BETA BIONICS INC | COM | 08659B102 | 19,505,762 | 1,593,608 | SH | SOLE | 1,593,608 | 0 | 0 | |||
| BIODESIX INC | COM | 09075X108 | 1,358,675 | 2,173,880 | SH | SOLE | 2,173,880 | 0 | 0 | |||
| BOSTON SCIENTIFIC CORP | COM | 101137107 | 13,114,400 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | 16,038,489 | 444,649 | SH | SOLE | 444,649 | 0 | 0 | |||
| CARGO THERAPEUTICS INC | COM | 14179K101 | 9,894,515 | 2,431,085 | SH | SOLE | 2,431,085 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 23,882,641 | 2,362,279 | SH | SOLE | 2,362,279 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 43,720,880 | 3,040,395 | SH | SOLE | 3,040,395 | 0 | 0 | |||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 10,059,918 | 1,441,249 | SH | SOLE | 1,441,249 | 0 | 0 | |||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 606,357 | 80,100 | SH | SOLE | 80,100 | 0 | 0 | |||
| DELCATH SYS INC | COM NEW | 24661P807 | 5,886,632 | 462,422 | SH | SOLE | 462,422 | 0 | 0 | |||
| DEXCOM INC | COM | 252131107 | 12,155,620 | 178,000 | SH | SOLE | 178,000 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 7,446,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 24,198,195 | 2,313,403 | SH | SOLE | 2,313,403 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 144,041,216 | 6,547,328 | SH | SOLE | 6,547,328 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 11,000,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | ||
| ENSYSCE BIOSCIENCES INC | COM NEW | 293602504 | 221,865 | 86,666 | SH | SOLE | 86,666 | 0 | 0 | |||
| EVOLUS INC | COM | 30052C107 | 49,673,578 | 4,129,142 | SH | SOLE | 4,129,142 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 8,332,025 | 1,537,274 | SH | SOLE | 1,537,274 | 0 | 0 | |||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 4,497,400 | 398,000 | SH | SOLE | 398,000 | 0 | 0 | |||
| IMMATICS N.V | SHS | N44445109 | 42,319,387 | 9,383,456 | SH | SOLE | 9,383,456 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 48,605,190 | 2,844,072 | SH | SOLE | 2,844,072 | 0 | 0 | |||
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | 12,975,750 | 5,925,000 | SH | SOLE | 5,925,000 | 0 | 0 | |||
| INHIBRX BIOSCIENCES INC | COM | 45720N103 | 14,885,723 | 1,064,026 | SH | SOLE | 1,064,026 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 38,854,497 | 509,300 | SH | SOLE | 509,300 | 0 | 0 | |||
| INSULET CORP | COM | 45784P101 | 18,802,088 | 71,597 | SH | SOLE | 71,597 | 0 | 0 | |||
| INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 103,736,347 | 786,358 | SH | SOLE | 786,358 | 0 | 0 | |||
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 20,117,372 | 40,619 | SH | SOLE | 40,619 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 42,330,254 | 12,711,788 | SH | SOLE | 12,711,788 | 0 | 0 | |||
| JANUX THERAPEUTICS INC | COM | 47103J105 | 26,201,124 | 970,412 | SH | SOLE | 970,412 | 0 | 0 | |||
| KALA BIO INC | COM NEW | 483119202 | 1,590,705 | 277,610 | SH | SOLE | 277,610 | 0 | 0 | |||
| KESTRA MED TECHNOLOGIES LTD | SHS | G52441105 | 4,984,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 485,227 | 139,835 | SH | SOLE | 139,835 | 0 | 0 | |||
| LYRA THERAPEUTICS INC | COM | 55234L105 | 1,607,453 | 12,757,562 | SH | SOLE | 12,757,562 | 0 | 0 | |||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 15,402,195 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | |||
| MEIRAGTX HLDGS PLC | COM | G59665102 | 85,254,892 | 12,581,103 | SH | SOLE | 12,581,103 | 0 | 0 | |||
| MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 1,973,162 | 876,961 | SH | SOLE | 876,961 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 29,062,514 | 690,485 | SH | SOLE | 690,485 | 0 | 0 | |||
| NANOBIOTIX | SPONSORED ADS | 63009J107 | 376,090 | 105,053 | SH | SOLE | 105,053 | 0 | 0 | |||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 10,843,615 | 12,594,211 | SH | SOLE | 12,594,211 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES | COM | 64125C109 | 11,065,530 | 100,050 | SH | SOLE | 100,050 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 3,534,930 | 297,553 | SH | SOLE | 297,553 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 115,881,011 | 1,633,968 | SH | SOLE | 1,633,968 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 6,712,631 | 915,775 | SH | SOLE | 915,775 | 0 | 0 | |||
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | 4,319,088 | 1,004,439 | SH | SOLE | 1,004,439 | 0 | 0 | |||
| OPUS GENETICS INC | COM | 67577R102 | 4,246,285 | 4,325,000 | SH | SOLE | 4,325,000 | 0 | 0 | |||
| ORCHESTRA BIOMED HLDGS INC | COM | 68572M106 | 19,656,140 | 4,592,556 | SH | SOLE | 4,592,556 | 0 | 0 | |||
| OUTSET MED INC | COM NEW | 690145206 | 9,216,662 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 37,146,456 | 980,894 | SH | SOLE | 980,894 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 52,773,866 | 1,091,271 | SH | SOLE | 1,091,271 | 0 | 0 | |||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 5,391,115 | 4,418,947 | SH | SOLE | 4,418,947 | 0 | 0 | |||
| REPLIGEN CORP | COM | 759916109 | 16,515,879 | 129,801 | SH | SOLE | 129,801 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | *W EXP 12/17/202 | 76155X118 | 9,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 134,991,132 | 2,548,445 | SH | SOLE | 2,548,445 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 938,642 | 140,726 | SH | SOLE | 140,726 | 0 | 0 | |||
| SCPHARMACEUTICALS INC | COM | 810648105 | 1,315,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| SIONNA THERAPEUTICS INC | COM | 829401108 | 13,086,516 | 1,251,101 | SH | SOLE | 1,251,101 | 0 | 0 | |||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 107,646,713 | 1,506,602 | SH | SOLE | 1,506,602 | 0 | 0 | |||
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 44,054,590 | 11,906,646 | SH | SOLE | 11,906,646 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 37,324,644 | 2,313,272 | SH | SOLE | 2,313,272 | 0 | 0 | |||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 5,000 | 166,666 | SH | SOLE | 166,666 | 0 | 0 | |||
| TRAWS PHARMA INC | COM NEW | 68232V884 | 970,096 | 421,781 | SH | SOLE | 421,781 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 26,679,970 | 706,567 | SH | SOLE | 706,567 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 416,706,457 | 6,563,340 | SH | SOLE | 6,563,340 | 0 | 0 | |||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 12,292,471 | 509,005 | SH | SOLE | 509,005 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 8,892,244 | 659,662 | SH | SOLE | 659,662 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 10,914,620 | 325,324 | SH | SOLE | 325,324 | 0 | 0 | |||
| ZYMEWORKS INC | COM | 98985Y108 | 22,208,244 | 1,864,672 | SH | SOLE | 1,864,672 | 0 | 0 | |||